The DARPin® protein technology provides a novel platform in healthcare and has proven to be clinically successful with the development of an anti-vascularr endothelial growth factor (VEGF) DARPin® protein drug candidate for the treatment of macular degeneration [26]. This evidence concerns the gene VEGFA and macular degeneration.